1119 Results (Page 2 of 94)
Healthcare Services Markets Research Reports
Malaysia Patient Engagement Solutions Market Analysis
Malaysia's patient engagement solutions market is projected to grow from $27.35 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The main factors driving the growth would be rising healthcare investments, growing digital health adoption, and government support. The market is segmented by component, delivery mode, application, therapeutic area, functionality, and by end-user. Some of the major players include Nexuses Health, Avanade, Cerner, Wolter Kluwer, and McKesson.
Finland Patient Engagement Solutions Market Analysis
Finland's patient engagement solutions market is projected to grow from $35.72 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The main factors driving the growth would be the growing healthcare sector, advancements in technology, and government support. The market is segmented by component, delivery mode, application, therapeutic area, functionality, and by end-user. Some of the major players include Buddy Healthcare, Tietoevry, Oracle, IBM, and Siemens Healthineers.
Denmark Patient Engagement Solutions Market Analysis
Denmark's patient engagement solutions market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The main factors driving the growth would be increased adoption of digital health technologies, focus on patient-centered care, government solutions, and a growing aging population. The market is segmented by component, delivery mode, application, therapeutic area, functionality, and by end-user. Some of the major players include Monsenso, OpenTeleHealth, Wolters Kluwer, Oracle, and IBM.
Mexico Connected Healthcare Market Analysis
The Mexico-connected healthcare market is projected to grow from $995.4 Mn in 2022 to $7469.23 Mn by 2030, registering a CAGR of 28.65% during the forecast period of 2022 - 2030. The main factors driving the growth would be increasing technological adoption, the ageing population, the rising prevalence of chronic diseases and government support. The market is segmented by type, function and by application. Some of the major players include Okani, Prosperia, Cuentame, Medtronic, Honeywell, Siemens Healthineer and GE Healthcare.
Malaysia Connected Healthcare Market Analysis
The Malaysia-connected healthcare market is projected to grow from $106.69 Mn in 2022 to $798.09 Mn by 2030, registering a CAGR of 28.6% during the forecast period of 2022 - 2030. The main factors driving the growth would be increasing healthcare spending, the ageing population, high smartphone penetration and government support. The market is segmented by type, function and by application. Some of the major players include IHH Healthcare Berhad, Zuellig Pharma, Qualitas Medical Group, Siemens Healthineer, GE Healthcare and Medtronic.
Japan Connected Healthcare Market Analysis
The Japan-connected healthcare market is projected to grow from $4.13 Bn in 2022 to $31.44 Bn by 2030, registering a CAGR of 28.9% during the forecast period of 2022 - 2030. The main factors driving the growth would be the ageing population, shortage of healthcare workers, technological innovation and government support. The market is segmented by type, function and by application. Some of the major players include Sony, Hitachi, Fujitsu Limited, Apple, Cisco Systems, IBM and GE Healthcare.
Italy Connected Healthcare Market Analysis
The Italy-connected healthcare market is projected to grow from $1.59 Bn in 2022 to $11.41 Bn by 2030, registering a CAGR of 27.9% during the forecast period of 2022 - 2030. The main factors driving the growth would be the rising geriatric population, chronic disease prevalence, technological advancements and government support. The market is segmented by type, function and by application. Some of the major players include Reply, D0Eye, Plusimple, Philips Healthcare, IBM and Siemens Healthineers.
Indonesia Connected Healthcare Market Analysis
The Indonesia-connected healthcare market is projected to grow from $398.16 Mn in 2022 to $2941.56 Mn by 2030, registering a CAGR of 28.4% during the forecast period of 2022 - 2030. The main factors driving the growth would be rising healthcare spending, chronic disease burden, and government support. The market is segmented by type, function and by application. Some of the major players include Halodoc, Alodokter, SehatQ, Good Doctor, Medtronic and Honeywell.
India Connected Healthcare Market Analysis
The India-connected healthcare market is projected to grow from $1.21 Bn in 2022 to $10.73 Bn by 2030, registering a CAGR of 31.4% during the forecast period of 2022 - 2030. The main factors driving the growth would be increasing healthcare needs, growing smartphone penetration, increasing healthcare spending and government initiatives. The market is segmented by type, function and by application. Some of the major players include Practo, HeyDoc, Omron Healthcare, TATA 1mg, Philips Healthcare, GE Healthcare, Cisco Systems and IBM.
Germany Connected Healthcare Market Analysis
The Germany-connected healthcare market is projected to grow from $2.43 Bn in 2022 to $16.03 Bn by 2030, registering a CAGR of 26.6% during the forecast period of 2022 - 2030. The main factors driving the growth would be the ageing population, strong healthcare infrastructure, research and development infrastructure and government support. The market is segmented by type, function and by application. Some of the major players include Siemens Healthineers, Fresenius Medical Care, CompuGroup Medical, Telekom Healthcare Solutions, Philips Healthcare, IBM, Medtronic, Apple and Honeywell.
France Connected Healthcare Market Analysis
The France-connected healthcare market is projected to grow from $1.83 Bn in 2022 to $12.67 Bn by 2030, registering a CAGR of 27.4% during the forecast period of 2022 - 2030. The main factors driving the growth would be government support, health tech startups and the rising geriatric population. The market is segmented by type, function and by application. Some of the major players include Sanofi, Withings, Voluntis, Evolucare, Apple, Microsoft, Siemens Healthineers and Medtronic.
China Connected Healthcare Market Analysis
The China-connected healthcare market is projected to grow from $5.34 Bn in 2022 to $43.25 Bn by 2030, registering a CAGR of 29.9% during the forecast period of 2022 - 2030. The main factors driving the growth would be a large and ageing population, government support, technological advancements and a rising middle class. The market is segmented by type, function and by application. Some of the major players include Tencent Health, JD Health International, WeDoctor, iCarbonX, Roche, GE Healthcare and Medtronic.
Australia Connected Healthcare Market Analysis
The Australia-connected healthcare market is projected to grow from $796.32 Mn in 2022 to $6444.96 Mn by 2030, registering a CAGR of 29.9% during the forecast period of 2022 - 2030. The main factors driving the growth would be the rising geriatric population, geographic challenges, technological innovation and government investment. The market is segmented by type, function and by application. Some of the major players include Telstra Health, HealthEngine, ResApp, MyHealth1st, Apple, IBM and Microsoft.
Brazil Connected Healthcare Market Analysis
The Brazil-connected healthcare market is projected to grow from $1.66 Bn in 2022 to $13.04 Bn by 2030, registering a CAGR of 29.4% during the forecast period of 2022 - 2030. The main factors driving the growth would be the growing demand for healthcare services, technological innovations, government initiatives and the ageing population. The market is segmented by type, function and by application. Some of the major players include Dr.Consulta, Grupo Fleury, Pixeon, Siemens Healthineers, GE Healthcare and Medtronic.
Egypt Connected Healthcare Market Analysis
The Egypt-connected healthcare market is projected to grow from $185.81 Mn in 2022 to $1506.39 Mn by 2030, registering a CAGR of 29.9% during the forecast period of 2022 - 2030. The main factors driving the growth would be increased adoption of digital technology, rising demand for healthcare services, improving internet penetration and government support. The market is segmented by type, function and by application. Some of the major players include 7keema, Tabibi 24/7, 3elagi, Siemens Healthineers, Microsoft and Apple.
Global Health Economics and Outcomes Research (HEOR) Services Market Analysis
The Global Health Economics and Outcomes Research (HEOR) Services Market is projected to grow from $1.5 Bn in 2022 to $3.6 Bn by 2030, registering a CAGR of 11.2% during the forecast period of 2022-2030. The market under study is anticipated to be dominated by North America. Factors such as increasing research and development expenditure by biotechnology and pharmaceutical companies across the countries in the region and booming clinical trials coupled with drug approvals, especially in the United States, are driving the growth of the HEOR services market in North America.
Global Real World Evidence (RWE) Solutions Market Analysis
The Global Real World Evidence (RWE) solutions market is projected to grow from $79.7 Bn in 2022 to $42.4 Bn by 2030, registering a CAGR of 8.2% during the forecast period of 2022-2030. AI and ML are being increasingly used in RWE solutions to analyze large amounts of data, identify trends, and generate insights. The major players in the RWE solutions market include IQVIA, Syneos Health, Parexel, Covance, and IMB, among others. These companies offer a range of RWE solutions and services to meet the needs of the industry.
Italy Clinical Diagnostics Market Analysis
The Italy clinical diagnostic market was valued at $1.65 Bn in 2022 and is estimated to expand at a CAGR of 5.5% from 2022-30 and will reach $2.53 Bn in 2030. One of the main reasons propelling the growth of this market is an increase in technology and the aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are Abbott, BD, bioMérieux, Sysmex, Giesse Diagnostics Srl, Diagnostic Center NSL Italy, Sentinel Diagnostics, DiaSorin, Menarini Diagnostics, Epitech Group and others.
US Clinical Diagnostics Market Analysis
The US clinical diagnostic market was valued at $28.95 Bn in 2022 and is estimated to expand at a CAGR of 4% from 2022-30 and will reach $39.61 Bn in 2030. One of the main reasons propelling the growth of this market is an increase in chronic disease and increased investment. The market is segmented by type, drug, and distribution channel. Some key players in this market are Abbott, bioMérieux, Danaher Corporation, Siemens, Qiagen, Quest Diagnostics, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Sysmex, Sonic Healthcare Ltd, Exact Sciences Corporation, NeoGenomics, Laboratory Corporation of America Holdings, and others.
UK Clinical Diagnostics Market Analysis
The UK Clinical Diagnostic market was valued at $1.79 Bn in 2022 and is estimated to expand at a CAGR of 4% from 2022-30 and will reach $2.45 Bn in 2030. One of the main reasons propelling the growth of this market is an increase in chronic disease and government support. The market is segmented by type, drug, and distribution channel. Some key players in this market are Abbott, Omega Diagnostics, Quest Diagnostics, F. Hoffmann-La Roche, LumiraDx, Diagnostics.ai, Thermo Fisher Scientific, Danaher Corporation, and others.
UAE Clinical Diagnostics Market Analysis
The UAE clinical diagnostic market was valued at $345 Mn in 2022 and is estimated to expand at a CAGR of 7% from 2022-30 and will reach $592 Mn in 2030. One of the main reasons propelling the growth of this market is an increase in chronic disease and government support. The market is segmented by type, drug, and distribution channel. Some key players in this market are Al Borg Laboratories, Aster DM, National Reference Laboratory, Fujifilm Middle Eas, Al Zahrawi Medical, Gulf Medical University, Life Medical Diagnostics, Abbott, BD, bioMérieux SA, Bio-Rad Laboratories, Danaher Corporation, Siemens F. Hoffmann-La Roche Ltd, and others.
Spain Clinical Diagnostics Market Analysis
Spain's clinical diagnostic market was valued at $1.3 Bn in 2022 and is estimated to expand at a CAGR of 5% from 2022-30 and will reach $1.9 Bn in 2030. One of the main reasons propelling the growth of this market is an increase in chronic disease and government support. The market is segmented by type, drug, and distribution channel. Some key players in this market are Abbott, BD, bioMérieux SA, Bio-Rad Laboratories, Danaher Corporation, Siemens AG, Hologic, Qiagen NV, Quest Diagnostics, F. Hoffmann-La Roche Ltd, Eurofins Megalab, Werfen Group, Grifols and others.
India Clinical Diagnostics Market Analysis
India's clinical diagnostic market was valued at $1.25 Bn in 2022 and is estimated to expand at a CAGR of 9% from 2022-30 and will reach $2.5 Bn in 2030. One of the main reasons propelling the growth of this market is an increase in chronic disease and government support. The market is segmented by type, drug, and distribution channel. Some key players in this market are Abbott, BD, bioMérieux SA, Bio-Rad Laboratories, Danaher Corporation, Siemens AG, Hologic, Qiagen NV, Quest Diagnostics, F. Hoffmann-La Roche Ltd, Thyrocare, Suburban Diagnostics, Metropolis Healthcare, SRL Diagnostics, Dr. Lal PathLabs, and others.
Global Clinical Diagnostics Market Analysis
The Global clinical diagnostic market was valued at $68.92 Bn in 2022 and is estimated to expand at a CAGR of 6% from 2022-30 and will reach $109.85 Bn in 2030. One of the main reasons propelling the growth of this market is an increase in chronic disease and the aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are Abbott, BD, bioMérieux SA, Bio-Rad Laboratories, Danaher Corporation, Siemens AG, Hologic, Qiagen NV, Quest Diagnostics, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Sysmex, Sonic Healthcare Ltd, Exact Sciences Corporation, NeoGenomics, Inc., BioReference Laboratories, Laboratory Corporation of America Holdings, DiaSorin, PerkinElmer, FUJIFILM Corporation, and others.
Germany Clinical Diagnostics Market Analysis
Germany's clinical diagnostic market was valued at $2.52 Bn in 2022 and is estimated to expand at a CAGR of 4.2% from 2022-30 and will reach $3.50 Bn in 2030. One of the main reasons propelling the growth of this market is an increase in chronic disease and government support. The market is segmented by type, drug, and distribution channel. Some key players in this market are Abbott, BD, bioMérieux SA, Bio-Rad Laboratories, Danaher Corporation, Siemens AG, Hologic, Qiagen NV, Quest Diagnostics, F. Hoffmann-La Roche Ltd, Merck and others.